Integer Holdings Corp

Integer Holdings Corporation operates as a medical device contract development and manufacturing organization serving the healthcare industry. The company operates through a single reportable business segment while deriving revenue across three principal product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation, and Other Markets. Its core offerings include components, sub-assemblies, and finished device systems, such as cardiac catheters, guidewires, introducers, stents, pacemakers, implantable pulse generators, leads, batteries, and specialized device coatings. Integer primarily serves large, multinational medical device original equipment manufacturers and their subsidiaries.

The company maintains corporate headquarters in Plano, Texas. Its operations feature a global manufacturing footprint with facilities located across the United States, Mexico, Uruguay, Ireland, Malaysia, Costa Rica, and the Dominican Republic. Integer distributes its products internationally, with approximately 53% of its goods shipped to locations within the United States. In addition, the organization held 731 domestic and foreign patents as of year-end 2025.

Summary of the business section of Integer's latest annual report, written by StockData.

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

“As of December 31, 2025, Integer employed approximately 11,000 associates in addition to a contingent workforce of approximately 400 to assist with various projects and service functions and address peaks in staff requirements.”